These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23098412)

  • 1. Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness.
    Gertsch JH; Corbett B; Holck PS; Mulcahy A; Watts M; Stillwagon NT; Casto AM; Abramson CH; Vaughan CP; Macguire C; Farzan NN; Vo BN; Norvelle RJ; May K; Holly JE; Irons H; Stutz AM; Chapagain P; Yadav S; Pun M; Farrar J; Basnyat B
    Wilderness Environ Med; 2012 Dec; 23(4):307-15. PubMed ID: 23098412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Double-Blinded Randomized Field-Based Clinical Trial of Metoclopramide and Ibuprofen for the Treatment of High Altitude Headache and Acute Mountain Sickness.
    Irons HR; Salas RN; Bhai SF; Gregorie WD; Harris NS
    Wilderness Environ Med; 2020 Mar; 31(1):38-43. PubMed ID: 32057631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories.
    Lipman GS; Kanaan NC; Holck PS; Constance BB; Gertsch JH;
    Ann Emerg Med; 2012 Jun; 59(6):484-90. PubMed ID: 22440488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Acetaminophen or Ibuprofen Results in Equivalent Acute Mountain Sickness Incidence at High Altitude: A Prospective Randomized Trial.
    Kanaan NC; Peterson AL; Pun M; Holck PS; Starling J; Basyal B; Freeman TF; Gehner JR; Keyes L; Levin DR; O'Leary CJ; Stuart KE; Thapa GB; Tiwari A; Velgersdyk JL; Zafren K; Basnyat B
    Wilderness Environ Med; 2017 Jun; 28(2):72-78. PubMed ID: 28479001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT).
    Gertsch JH; Lipman GS; Holck PS; Merritt A; Mulcahy A; Fisher RS; Basnyat B; Allison E; Hanzelka K; Hazan A; Meyers Z; Odegaard J; Pook B; Thompson M; Slomovic B; Wahlberg H; Wilshaw V; Weiss EA; Zafren K
    Wilderness Environ Med; 2010 Sep; 21(3):236-43. PubMed ID: 20832701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High altitude headache: efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial.
    Harris NS; Wenzel RP; Thomas SH
    J Emerg Med; 2003 May; 24(4):383-7. PubMed ID: 12745039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS; Jurkiewicz C; Winstead-Derlega C; Navlyt A; Burns P; Walker A; Phillips C; Reilly A; Burnier A; Romero J; Warner K; Hackett P
    High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased Cytokines at High Altitude: Lack of Effect of Ibuprofen on Acute Mountain Sickness, Physiological Variables, or Cytokine Levels.
    Lundeberg J; Feiner JR; Schober A; Sall JW; Eilers H; Bickler PE
    High Alt Med Biol; 2018 Sep; 19(3):249-258. PubMed ID: 29924642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
    BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgo biloba does--and does not--prevent acute mountain sickness.
    Leadbetter G; Keyes LE; Maakestad KM; Olson S; Tissot van Patot MC; Hackett PH
    Wilderness Environ Med; 2009; 20(1):66-71. PubMed ID: 19364166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID).
    Lipman GS; Kanaan NC; Phillips C; Pomeranz D; Cain P; Fontes K; Higbee B; Meyer C; Shaheen M; Wentworth S; Walsh D
    High Alt Med Biol; 2015 Jun; 16(2):154-61. PubMed ID: 25950723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m.
    Bloch KE; Turk AJ; Maggiorini M; Hess T; Merz T; Bosch MM; Barthelmes D; Hefti U; Pichler J; Senn O; Schoch OD
    High Alt Med Biol; 2009; 10(1):25-32. PubMed ID: 19326598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide.
    Burns P; Lipman GS; Warner K; Jurkiewicz C; Phillips C; Sanders L; Soto M; Hackett P
    Am J Med; 2019 Feb; 132(2):247-251. PubMed ID: 30419226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for preventing acute mountain sickness: a network meta-analysis and trial sequential analysis of randomized clinical trials.
    Sridharan K; Sivaramakrishnan G
    Ann Med; 2018 Mar; 50(2):147-155. PubMed ID: 29166795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent.
    Gertsch JH; Seto TB; Mor J; Onopa J
    High Alt Med Biol; 2002; 3(1):29-37. PubMed ID: 12006162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial.
    Jafarian S; Gorouhi F; Salimi S; Lotfi J
    Ann Neurol; 2007 Sep; 62(3):273-7. PubMed ID: 17557349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
    Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER
    High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK; Richer LD; Elstad MR
    Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
    Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C
    High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
    van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
    High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.